PARKINSON DISEASE

This study looked at whether a program of intensive physical activity could improve movement and reduce inflammation in people with Parkinson's disease. Researchers compared 30 patients who exercised with those who stayed sedentary, measuring changes in motor skills and blood mar…

This study tested an experimental drug called VENT-02 in 29 people with mild to moderate Parkinson's disease. The goal was to see if it is safe and how it affects inflammation in the body. The trial was stopped early, so results are limited.

This study tested a device called the Dysphagia Detection System (DDS) to see if it could accurately detect swallowing problems in people with conditions like stroke, Parkinson's disease, multiple sclerosis, Alzheimer's, or dementia. The device was compared to a standard X-ray te…

This early-stage study tested the safety of an experimental drug called talineuren, given through a vein, in 22 people with Parkinson's disease. The main goal was to see if the drug was safe and to find the best dose. The study was stopped early, so results are limited.

This study looked at whether istradefylline, a drug already approved for motor symptoms in Parkinson's disease, could also help with apathy—a common problem where people lose interest and motivation. The study planned to track changes in physical activity and engagement over 12 w…

This study looked at whether using walking poles during an 8-week walking program could improve walking and activity levels in people with Parkinson's disease. Participants wore a sensor to track their movement and had their walking measured before and after the program. The stud…

This study tested whether a robotic walking trainer (G-EO System) is safe and helpful for people with Parkinson's disease who have trouble walking. Fifteen participants used the robot to practice walking, and researchers measured their speed, mobility, and quality of life. The tr…

This study tested an inhaler called Staccato Apomorphine (AZ-009) to quickly relieve 'OFF' episodes in people with Parkinson's disease—times when symptoms return between medication doses. The trial planned to include patients who had daily OFF episodes, but it was terminated earl…